The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Salesforce, Inc. (CRM), Shell plc ...

In a report released yesterday, Jasper Hellweg from Argus Research maintained a Buy rating on Novo Nordisk (NVO – Research Report). The ...

N-Power Medicine, backed by Merck GHI, announced the acquisition of Syapse Holdings. Samsung Biologics and LigaChem extended their ADC services deal. Publicis Worldwide merged with Leo Burnett to form ...

The FDA has narrowly beaten the European Medicines Agency (EMA) to the most approved drugs with a new active substance in ...

While the deals done this week are important for the future direction of the industry – US company Gilead (US:GILD) inked the biggest, paying up to $1.7bn for Leo Pharma’s range of pre-clinical ...

About two and a half years after originating the role of chief commercial officer at Arvinas, John Northcott is leaving his post at the biotech. | About two and a half years after originating the role ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

America's pharmaceutical founding fathers Meanwhile ... With its hepatitis C drugs, Gilead faced huge amounts of controversy over the initial costs of its therapies, although these were reduced ...

Pfizer named Dr Chris Boshoff as CSO and president of R&D, effective 1st January 2025. Boshoff, previously Pfizer’s chief ...

Discover investment opportunities in lesser-covered stocks like Arcus Biosciences, Sarepta Therapeutics, and Edison International.

U.S. Food and Drug Administration (FDA) Commissioner Robert Califf testifies before a House Appropriations Subcommittee hearing on President Biden's proposed budget request for the FDA for fiscal ...

Selective stock-picking and conviction drove HB Biotech’s strong 2024 performance. Read our insights on navigating today’s ...